Molecular Cancer Therapeutics, 1535-7163

Journal

Publications

  1. 2008
  2. Published
  3. Published
  4. 2010
  5. Published
  6. Published
  7. Published
  8. 2011
  9. Published
  10. 2012
  11. Published

    Targeted mutations in the ATR pathway define agent-specific requirements for cancer cell growth and survival

    Eva Petermann, Jan 2012, In: Molecular Cancer Therapeutics. 11, 1, p. 98-107 10 p.

    Research output: Contribution to journalArticlepeer-review

  12. 2014
  13. Published
  14. 2015
  15. Published

    Anticancer properties of a novel class of tetrafluorinated thalidomide analogues

    Chris Mahony, Oct 2015, In: Molecular Cancer Therapeutics. 14, 10, p. 2228–2237 10 p.

    Research output: Contribution to journalArticlepeer-review